Altered sperm function or sperm antibodies are not associated with chlamydial antibodies in infertile men with leucocytospermia

Author(s):  
Barbara Habermann ◽  
Walter Krause
1988 ◽  
Vol 9 (6) ◽  
pp. 384-389 ◽  
Author(s):  
CHRISTINA WANG ◽  
STEVEN Y. W. CHAN ◽  
MATTHEW NG ◽  
WILLIAM W. K. SO ◽  
WAI-LOONG TSOI ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (3) ◽  
pp. 219 ◽  
Author(s):  
Mohamed Arafa ◽  
Ashok Agarwal ◽  
Ahmad Majzoub ◽  
Manesh Kumar Panner Selvam ◽  
Saradha Baskaran ◽  
...  

Antioxidants are used in the empirical treatment of infertile men. The aim of this study was to evaluate the effects of antioxidant therapy on conventional semen parameters and advanced sperm function tests in men seeking fertility treatment. A total of 148 infertile men of unknown etiology were divided into idiopathic (n = 119) and unexplained male infertility (UMI; n = 29). All participants were treated with the antioxidant supplement ‘FH PRO for Men’ for a period of three months. Compared with pretreatment results, there was a significant improvement in conventional semen parameters including sperm concentration, total and progressive motility and normal morphology, and seminal oxidation reduction potential (ORP), and sperm DNA fragmentation (SDF) in idiopathic infertile men. The changes were more prominent in idiopathic infertile men positive for ORP and SDF. UMI patients showed an improvement in progressive motility, ORP, and SDF after antioxidant treatment. Statistical analysis revealed that the efficacy of FH PRO for Men was significant in idiopathic male infertility compared with UMI. Treatment of idiopathic male infertility patients with the FH PRO for Men antioxidant regimen for three months resulted in a significant improvement in conventional semen parameters and sperm function. Therefore, FH PRO for Men offers promise for the medical treatment of idiopathic male infertility.


Andrologia ◽  
2009 ◽  
Vol 26 (2) ◽  
pp. 55-60 ◽  
Author(s):  
P. Vigil ◽  
C. Wöhler ◽  
E. Bustos-Obregón ◽  
F. Comhaire ◽  
P. Morales
Keyword(s):  

Andrology ◽  
2018 ◽  
Vol 6 (2) ◽  
pp. 325-334 ◽  
Author(s):  
A. Garolla ◽  
I. Šabović ◽  
S. Tescari ◽  
L. De Toni ◽  
M. Menegazzo ◽  
...  
Keyword(s):  

1994 ◽  
Vol 32 (2) ◽  
pp. 88-94 ◽  
Author(s):  
R. Paschke ◽  
D. Schulze Bertelsbeck ◽  
K. Tsalimalma ◽  
E. Nieschlag

2019 ◽  
Vol 09 (08) ◽  
pp. 1130-1141
Author(s):  
Maindo Alongo Mike-Antoine ◽  
Juakali Sihalikyolo ◽  
Salomon Batina Agasa ◽  
Antoine Modia O’yandjo ◽  
Bernard Mbutu ◽  
...  

2020 ◽  
Author(s):  
Simon Schneider ◽  
Farhad Shakeri ◽  
Christian Trötschel ◽  
Lena Arévalo ◽  
Alexander Kruse ◽  
...  

AbstractProtamines are the safeguards of the paternal sperm genome. They replace most of the histones during spermiogenesis, resulting in DNA hypercondensation, thereby protecting its genome from environmental noxa. Impaired protamination has been linked to male infertility in mice and humans in many studies. Apart from impaired DNA integrity, protamine-deficient human and murine sperm show multiple secondary effects, including decreased motility and aberrant head morphology. In this study, we use a Prm2-deficient mouse model in combination with label-free quantitative proteomics to decipher the underlying molecular processes of these effects. We show that loss of the sperm’s antioxidant capacity, indicated by downregulation of key proteins like SOD1 and PRDX5, ultimately initiates an oxidative stress-mediated destruction cascade during epididymal sperm maturation. This is confirmed by an increased level of 8-OHdG in epididymal sperm, a biomarker for oxidative stress-mediated DNA damage. Prm2-deficient testicular sperm are not affected and initiate the proper development of blastocyst stage preimplantation embryos in vitro upon intracytoplasmic sperm injection (ICSI) into oocytes. Our results provide new insight into the role of Prm2 and its downstream molecular effects on sperm function and present an important contribution to the investigation of new treatment regimens for infertile men with impaired protamination.Significance statementSexual reproduction requires the successful fertilization of female eggs by male sperm. The generation of functional sperm is a complex, multi-step differentiation process known as spermatogenesis that takes places in the male testis. One important step for physiological sperm function is the incorporation of small proteins, known as protamines into the DNA. Defects within this process are common causes of male infertility. However, the underlying molecular mechanisms still remain largely unknown, thus preventing targeted therapies. Here, we identify the molecular cascade being initiated in protamine-deficient murine sperm that ultimately impedes fertilization. Our findings have broad implications for the development of new treatment options for infertile men with faulty protamination that seek medical advice.


Author(s):  
Ignacio A. Cardeña ◽  
Andrea C. Andrade Rodríguez ◽  
Edgar O. Ruiz Treviño ◽  
Junior J. Araiza Navarro ◽  
Enrique R. Muñoz ◽  
...  

Background: The first immunological correlation with male infertility was reported in 1954 by Wilson and Rumke with the identification of anti-sperm antibodies. The prevalence of anti-sperm antibodies in infertile men varies from 9%-36%, the main cause being the loss of the blood-testicular barrier and otherwise the association with chronic inflammation. It has been shown that immune infertility is found in 15% of patients with varicocele.Methods: A transversal comparative study was carried out with 360 infertile men who were tested for anti-sperm antibodies between January 2011 and July 2018. Two groups were integrated; Group 1, infertile men with positive anti-sperm antibodies >50%, group 2, infertile men with negative anti-sperm <50%. Seminogram parameters were evaluated according to the WHO 5th edition and associated risk factors with anti-sperm antibodies.Results: 360 infertile men were evaluated during the study, 42 were excluded because they did not meet the inclusion criteria, the prevalence of anti-sperm antibodies was 14.5%. Group 1; n=46 (14.5%) and group 2, n=272 (85.5%), the clinical characteristics and the hormonal profile were compared at study admission without significant difference. There was a significant decrease in progressive motility in group 1 (38.7±23.8) vs group 2 (50.1±18.9) p=0.03. Analyzing the risk factors, varicocele was found to be significant 23.7%, OR 2.14 (1.27-3.61) p=0.004 as well as retractable testicle 26.4%, OR 2.13 (1.23-3.70) p= 0.008.Conclusions: The affectation of motility was confirmed, which leads to the suspect varicocele and retractable testicle as risk factors.


Sign in / Sign up

Export Citation Format

Share Document